Benjamin Thomas
Podiatrist · Providence, UTNPI 1043659055
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,637 of the $2,332 with a category attached, or 70.2%. 33 manufacturers reported payments, led by Paragon 28, Inc. at 33.7% of the total. 2025 is the largest year on record at $1,011, 3.1 times the $322 reported in 2019.
Across 86 payments — averaging $27.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$787
- Anika Therapeutics, Inc.$164
- Zyla Life Sciences, Inc.$160
- Averitas Pharma Inc.$150
- Amgen$115
- Boehringer Ingelheim$92
- plus $865 from 27 others
What the payments were for
- Travel & lodging$69530%
- Food & beverage$1,63770%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 5 | $787 |
| Anika Therapeutics, Inc. | 2 | $164 |
| Zyla Life Sciences, Inc. | 22 | $160 |
| Averitas Pharma Inc. | 6 | $150 |
| Amgen(2 entities) | 6 | $115 |
| Boehringer Ingelheim | 5 | $92 |
| Stryker | 2 | $90 |
| Nevro Corp. | 1 | $86 |
| Johnson & Johnson(2 entities) | 3 | $69 |
| Paratek Pharmaceuticals, Inc. | 4 | $68 |
| Lilly USA, LLC | 3 | $50 |
| Boston Scientific | 3 | $47 |
| ANI Pharmaceuticals, Inc. | 2 | $47 |
| Quidel Corporation | 1 | $41 |
| Solventum Corporation | 2 | $39 |
| Medtronic | 2 | $32 |
| Zimmer Biomet | 1 | $27 |
| Smith+Nephew | 1 | $25 |
| Siemens Medical Solutions USA, Inc. | 1 | $25 |
| AbbVie | 1 | $22 |
| Organogenesis Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Vertex | 1 | $17 |
| Gilead | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Urgo Medical North America, LLC | 1 | $15 |
| Bayer | 1 | $15 |
| Seqirus USA Inc | 1 | $14 |
| Axonics, Inc. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Dynavax Technologies Corporation | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Precision MIS Bunion$487
- Portfolio$208
- TACTOSET$146
How this compares
$2,332 in reported general payments places this provider in the 65th percentile of 59 podiatrist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 16 | $168 |
| Cephalexin | 12 | $158 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Providence
- Jason BruseLayton$203K
- Anna HronekSalt Lake City$82K
- Michele CarrDraper$56K
- David GraffOgden$39K
- Clark LarsenMurray$16K
- Kelly HamblinWest Jordan$13K
- Mikol AndersonSalt Lake City$9K
- Thomas EddyMurray$7K
- Andrew EvansSt George$6K
- Jason LucasOgden$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.